A Study to Test How Different Doses of BI 1015550 Are Taken up in the Body of Healthy Japanese Men
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT06139302
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 92
- Registration Number
- NCT06139315
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 32
- Registration Number
- NCT06139341
- Locations
- 🇯🇵
Clinical Research Hospital Tokyo, Tokyo, Shinjuku-ku, Japan
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
- Conditions
- Interventions
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 55
- Registration Number
- NCT06132113
- Locations
- 🇧🇪
Brussels - UNIV Saint-Luc, Bruxelles, Belgium
🇺🇸University of Miami, Miami, Florida, United States
🇧🇪Edegem - UNIV UZ Antwerpen, Edegem, Belgium
Real-world Study of Dedifferentiated Liposarcoma Patients in China
- Conditions
- First Posted Date
- 2023-11-03
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1390
- Registration Number
- NCT06115681
- Locations
- 🇨🇳
Beijing Jishuitan hospital, Beijing, China
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 46
- Registration Number
- NCT06107036
- Locations
- 🇬🇧
Quotient Sciences, Nottingham, United Kingdom
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
- Conditions
- Interventions
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 70
- Registration Number
- NCT06091930
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, China
🇯🇵National Cancer Center Hospital East, Chiba, Kashiwa, Japan
🇯🇵National Cancer Center Hospital, Tokyo, Chuo-ku, Japan
A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly
- Conditions
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 22
- Registration Number
- NCT06082843
- Locations
- 🇺🇸
Inland Empire Clinical Trials, LLC, Rialto, California, United States
🇨🇳Beijing Friendship Hospital, Beijing, China
🇫🇷HOP Beaujon, Clichy, France
A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 64
- Registration Number
- NCT06081530
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 4935
- Registration Number
- NCT06077864
- Locations
- 🇺🇸
Verus Clinical Research Corporation, Miami, Florida, United States
🇺🇸IMA Clinical Research San Antonio, San Antonio, Texas, United States
🇺🇸Synexus Clinical Research, Salt Lake City, Utah, United States